With more than 40 years in small-molecule manufacturing, Ajinomoto Bio-Pharma Services develops and produces pharmaceutical APIs and intermediates for drug companies worldwide. Its CDMO capabilities span the path from preclinical work through commercialization, while on-site analytical laboratories characterize molecules and support quality testing throughout their life cycle. Through Forge Biologics, a member of Ajinomoto Bio-Pharma Services, the company also provides AAV and plasmid manufacturing from preclinical through commercial stages.
Forge BiologicsFounded by gene therapy developers for developers, Forge Biologics is a Columbus, Ohio-based contract development and manufacturing organization focused on AAV gene therapy development and production. Its 200,000-plus-square-foot Hearth facility has 20 cGMP suites and supports programs from research through clinical and commercial manufacturing. Forge is part of Ajinomoto Bio-Pharma Services and brings more than 450 experts to its work with gene therapy developers.GROVE CITY, OH
Curia Global, IncFounded in Albany in 1991 as Albany Molecular Research, Curia is a global contract research, development and manufacturing organization serving pharmaceutical and biotechnology companies from drug discovery through commercial production. The company now operates an integrated network of more than 20 facilities across North America, Europe and India, with more than 3,000 professionals supporting small-molecule and biologics programs. Curia’s history includes discovery and development of the active pharmaceutical ingredient in Allegra and deep experience scaling complex APIs, sterile drug products and biologics.ALBANY, NY
Gyma Laboratories of America, IncEstablished in 1951, Gyma Laboratories of America connects pharmaceutical companies with the active ingredients, development partners, and regulatory support needed to move drugs from research toward market. The company has supplied APIs to the U.S. pharmaceutical industry for more than 70 years and now operates across North America, Europe, and Asia, with newer capabilities in biotechnology and mRNA development. Its work spans the drug life cycle, including support for more than 1,000 first-to-market APIs under ANDA filings since 1971.WOODBURY, NY
Pharmaceutics International, Inc. (Pii)Founded in 1994, Pharmaceutics International, Inc. (Pii) is a Hunt Valley drug product contract development and manufacturing organization that takes pharmaceutical products from early development through clinical trials and commercial production. Now part of Jabil, Pii combines more than 30 years of complex-formulation experience with a 360,000-square-foot, four-site campus and more than 300 scientists and support staff. Its GMP facilities are built for demanding work, including potent compounds, complex injectables and oral drug products, with FDA-licensed and DEA-registered operations.HUNT VALLEY, MD